Literature DB >> 27236133

Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.

Steven Fishbane1.   

Abstract

Iron supplementation is an important aspect of treatment for hemodialysis patients, with most administration by an intravenous route. As with any drug, decisions as to treatment are most meaningful when benefits and risks are weighed in the context of the individual patient's clinical characteristics. In this article, knowledge of benefits and risks of intravenous iron are reviewed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anemia; drug safety; iron deficiency; iron treatment

Mesh:

Substances:

Year:  2016        PMID: 27236133     DOI: 10.1016/j.semnephrol.2016.02.006

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  3 in total

1.  What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: Balancing Benefits and Safety with Intravenous Iron Treatment.

Authors:  M Alan Brookhart; Xiaojuan Li; Abhijit V Kshirsagar
Journal:  Semin Dial       Date:  2016-10-20       Impact factor: 3.455

Review 2.  Intravenous Irons: From Basic Science to Clinical Practice.

Authors:  Sunil Bhandari; Dora I A Pereira; Helen F Chappell; Hal Drakesmith
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

Review 3.  Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease.

Authors:  Ole Haagen Nielsen; Christoffer Soendergaard; Malene Elbaek Vikner; Günter Weiss
Journal:  Nutrients       Date:  2018-01-13       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.